Max Mousseron Institute of Biomolecules (IBMM)
The IBMM conducts research on biomolecules (lipids, sugars, proteins, and DNA/RNA), which are the building blocks of life. This research at the intersection of chemistry and biology contributes to a better understanding of physiological and pathophysiological mechanisms, as well as to the development of innovative tools for healthcare: new, more effective treatments (for cancer, cardiovascular diseases, and neurodegenerative diseases), new medical devices, new approaches in cosmetology, and new diagnostic systems.
The IBMM teams' areas of expertise include:
- the design of biomolecules and their derivatives using molecular modeling, and their synthesis through more efficient, environmentally friendly methods;
- the development of analytical methods for characterizing biomolecules and analyzing them in biological systems;
- in vitro pharmacological, toxicological, and biological studies of these biomolecules to validate their properties and select the most promising ones for further development into new therapeutic and diagnostic systems and devices;
- The IBMM’s expertise makes it a unique laboratory for commercializing its research, which has led, in particular, to the launch of two drugs (Macrilen, Sébivo) and the creation of several companies.
Immersion at IBMM offers a unique educational experience for students who wish to tackle the future challenges facing the life sciences.
Label:Joint Research Unit Research UMR)
; Main sponsoring organizations: CNRS, UM,ENSCM
; Research cluster: Chemistry
; Doctoral schools:BALARD Chemical Sciences;Chemical and Biological Sciences for Health
; HAL portal: the unit’s publications
